STSA

Satsuma Pharmaceuticals (STSA)

Satsuma Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:STSA

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/06/21	02 : 03	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/15	21 : 00	GlobeNewswire Inc.	Satsuma Pharmaceuticals and SNBL Announce Three Abstracts on STS101 for the Acute Treatment of Migraine to be Presented at the American Headache Society’s 65th Annual Scientific Meeting	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/13	06 : 01	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/09	19 : 04	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/09	19 : 04	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/09	05 : 46	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/09	05 : 44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/09	05 : 44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/09	05 : 38	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/09	05 : 33	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/09	05 : 32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/09	05 : 31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/09	05 : 25	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/08	22 : 23	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/08	22 : 22	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/08	22 : 20	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/08	22 : 19	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/08	22 : 18	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/08	22 : 18	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/08	22 : 17	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/08	22 : 17	Edgar (US Regulatory)	Amended Statement of Ownership: Private Transaction (sc 13e3/a)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/08	22 : 17	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/08	22 : 15	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/08	22 : 14	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/08	22 : 13	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/08	22 : 12	Edgar (US Regulatory)	Amended Statement of Ownership: Private Transaction (sc 13e3/a)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/05/31	19 : 04	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/05/31	19 : 03	Edgar (US Regulatory)	Amended Statement of Ownership: Private Transaction (sc 13e3/a)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/05/26	19 : 40	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/05/25	19 : 04	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc